- Report
- February 2024
- 120 Pages
Asia Pacific
From €4756EUR$4,950USD£4,083GBP
- Report
- May 2024
- 183 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Report
- November 2023
- 148 Pages
Global
From €4276EUR$4,450USD£3,671GBP
- Book
- April 2018
- 224 Pages
- Book
- July 2014
- 224 Pages
- Book
- June 2012
- 596 Pages
- Book
- April 2023
North America
Vasculitis is a group of disorders that involve inflammation of the blood vessels. It is a subset of Allergy and Immunology, which is the study of the body's immune system and its response to foreign substances. Symptoms of vasculitis can include fever, fatigue, joint pain, and skin rashes. Treatment typically involves medications such as corticosteroids, immunosuppressants, and biologics.
Vasculitis is a rare condition, but it can have serious consequences if left untreated. Early diagnosis and treatment are important for managing the condition and preventing long-term complications. Research is ongoing to better understand the causes and develop new treatments.
Companies in the Vasculitis market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more